Poole Jonathan

Poole Jonathan is listed in filings as Director at ACADIA Pharmaceuticals Inc.. This profile follows SEC Form 4 activity through Jun 1, 2026, including 7 public disclosures. Recent filings connect the profile to ACADIA Pharmaceuticals Inc. (ACAD). The current snapshot covers public activity from Mar 20, 2026 to Jun 1, 2026. Reported amounts are shown as $346.6K to $80.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.